SciELO - Scientific Electronic Library Online

 
vol.46 número3Valoración de la formación de niños en reanimación cardiopulmonar mediante cuentos y dibujos animadosÉxito de tratamiento conservador ambulatorio de paciente con ascitis quilosa tras hemicolectomía izquierda laparoscópica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Anales del Sistema Sanitario de Navarra

versión impresa ISSN 1137-6627

Resumen

RODRIGUEZ-ESQUIROZ, Andrea et al. Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients. Anales Sis San Navarra [online]. 2023, vol.46, n.3, e1056.  Epub 18-Mar-2024. ISSN 1137-6627.  https://dx.doi.org/10.23938/assn.1056.

Background.

The oral antiviral nirmatrelvir/ritonavir interacts with a range of drugs. Candidate patients to receive this antiviral agent are usually vulnerable, multipathological and polymedicated. The objective is to evaluate the pharmaceutical validation prior to the administration of the antiviral.

Material and methods.

Drug-drug interactions between nirmatrelvir/ritonavir and patients’ usual treatment medications were checked in product information and in the UpToDate® and the University of Liverpool® interaction tools. We included validated prescriptions between April/2022 and April/2023 by a Primary Care pharmacist.

Results.

Of the 159 study patients, 168 interactions were found in 83 individuals, which may have led to changes of their usual treatment. Statins (25.6%), anticoagulants (10.7%), and antihypertensives (10.7%) were the most frequently implicated therapeutic groups. Discontinuation (53.0%) and dose reduction (22.6%) were the most common treatment changes.

Conclusions.

Our search of potential drug interactions and subsequent dose adjustments and modifications of the patient’s usual treatment has helped avoid potential toxicities ensuring a safe use of nirmatrelvir/ritonavir.

Palabras clave : Antiviral Agents; Drug Interactions; COVID-19 Drug Treatment; Patient Safety; Primary Health Care.

        · resumen en Español     · texto en Español     · Español ( pdf )